Sistemi Anticoagulanti in Circolazione Extracorporea

Craddock P.R. , Fehr J. , Bri-gham K.L. , Kronenberg R.S. , Jacob H.S. . Complement and leucocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977; 296: 769.

Jacob H.S. , Craddock P.R. , Hammerschmidt D.E. , Moldow D.F. . Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. N Engl J Med 1980; 302: 89.

Benis J. , Rigney J. , Sosin A. , Deane N. . Enhanced platelet aggregation in chronic renal failure patients receiving haemodialysis treatment. ASAIO, 1977; 23: 48.

Schwab S.J. , Onorato J.J. , Sharar L.R. , Dennis P.A. . Hemodialysis without anticoagulation: one year prospective trial in hospitalized patients at risk of bleeding. Am J Med 1987; 83: 405.

Naito H. , Miyazaki T. , Obata S. Analitical study of protein deposits on the inner surface of EVAL, hollow fiber membrane in non-anticoagulant haemodialysis (NAHD). Jap J Artif Organs, 12: 2; 642.

Thomson C. , Forbes C.D. , Prentice C.R. . The potentiation of platelet aggregation by heparin in vitro and in vivo. Clin Sci Mod Med, 1973; 45: 485.

Lindsay R.M. , Ferguson D. , Prentice C.R.M. , Burton J.A. , McNicol G.P. . Reduction of thrombus formation on dialy-zer membranes by aspirin and RA233. Lancet 1972; 2: 1287.

Gotch F.A. , Keen M.L. . Precise control of minimal heparinization for high bleeding risk hemodialysis. Trans ASAIO 1977; 23: 168.

Farrell P.C. , Ward R.A. , Schindhelm K. , Gotch F.A. . Precise anticoagulation for routine hemodialysis. J Lab Clin Med 1978; 92: 164.

Rucinski B. , Niewiarowski J. , Jones P. , Walz D.A. , Budzynski A.Z. . Antiheparin proteins secreted by human platelets: purification, characterization and radioimmunoassay. Blood 1979; 53: 47.

Winearls G.G. , Oliver D.O. , Pip-pard M.J. , Reid C. , Downing M.R. , Cater P.M. . Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients man-tained by chronic haemodialysis. Lancet 1986; 2: 1175.

Lindsay R. , Smith A.M. . Replacement of renal function by dialysis: practical use of anticoagulant: 3rd ed. Dordrecht: Maher JF, 1989.

Renand H. , Mariniere P. , Die-val J. Low molecular weight heparin in haemodialysis and haemofiltration. Comparison with unfractioned heparin. Proocedings EDTA-E-RA, 1984; 21: 276–80.

Schwartz R.A. , Port F.K. . Preventing hemorragic in high risk hemodialysis; regional versus low-dose heparin. Kidney Int 1979; 10: 513.

Pinnick R.V. , Wiegmann T.B. , Diderich A.M. . Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Eng J Med 1983; 380: 258.

Flanigan M.J. , von Brecht J. , Freeman R.M. , Lim V.S. . Reducing the hemorrhagic complications of HD: a controlled comparison of low dose citrate anticoagulation. Am J Kidney Dis 1987; 9: 147.

Turney J.H. , Fewell M.R. , Williams L.C. , Parsons V. , Weston M.J. . Platelet protection and heparin sparing with prostacyclin regular dialysis therapy. Lancet 1980; 2: 219.

Zusman R.M. , Rubin R.H. , Cato A.E. , Cocchetto D.M. , Crow J.W. , Tolkoff-Rubin N. . Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med 1981; 304: 934.

Rylance P.B. , Gordge M.P. , Ireland H. , Lane D.A. , Weston M.J. . Haemodialysis with prostacyclin (Epoprostenol) alone. Proc Eur Dial Transplant Assoc 1984; 21: 281.

Maurin N. , Ballmann M. . Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG4203 and low-dose heparin. Clin Nephrol 1988; 30: 35.